24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Barbara Gitlitz is a medical oncologist in Los Angeles, California. She got her medical degree from Stony Brook University School of Medicine and did an internship at UCLA Medical Center. Dr. Gitlitz completed a residency at Cedars-Sinai Medical Center and a fellowship at UCLA Medical Center. She is certified in medical oncology and has more than 20 years of experience. Currently Dr. Gitlitz is affiliated with Keck Hospital of USC and USC Norris Cancer Hospital.
Stony Brook University School of Medicine
Medical School
UCLA Medical Center
Internship
Cedars-Sinai Medical Center
Residency
UCLA Medical Center
Fellowship
American Board of Internal Medicine - Oncology
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer
Carter, C. A.,Rajan, A.,Keen, C.,Szabo, E.,Khozin, S.,Thomas, A.,Brzezniak, C.,Guha, U.,Doyle, L. A.,Steinberg, S. M.,Xi, L.,Raffeld, M.,Tomita, Y.,Lee, M. J.,Lee, S.,...; Ann. Oncol.. 2016 Jan 24.
See more >>
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWO.
Lara, P. N.,Moon, J.,Redman, M. W.,Semrad, T. J.,Kelly, K.,Allen, J.,Gitlitz, B.,Mack, P. C.,Gandara, D. R.; Clin Lung Cancer. 2015 Oct 27.
See more >>
I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sen
Ou, S. H.,Greenbowe, J.,Khan, Z. U.,Azada, M. C.,Ross, J. S.,Stevens, P. J.,Ali, S. M.,Miller, V. A.,Gitlitz, B.; Lung Cancer. 2015 Mar 05.
See more >>Memberships
American Association for Cancer Research
American Society of Clinical Oncology
International Association for the Study of Lung Cancer
Southwestern Oncology Group
